Australia markets open in 5 hours 37 minutes

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
461.04+10.47 (+2.32%)
As of 12:23PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close450.57
Open454.49
Bid461.03 x 900
Ask461.66 x 900
Day's range454.95 - 462.57
52-week range418.01 - 664.64
Volume364,132
Avg. volume1,038,306
Market cap49.392B
Beta (5Y monthly)0.16
PE ratio (TTM)15.11
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • 2 Best Pharma Stocks to Buy Right Now
    Motley Fool

    2 Best Pharma Stocks to Buy Right Now

    Regeneron Pharmaceuticals (NASDAQ: REGN) and AbbVie (NYSE: ABBV) have managed to deliver strong fourth quarter earnings. Regeneron Pharmaceuticals' fiscal 2020 performance has been quite remarkable, considering the many pressures it faced due to COVID-19 related restrictions. Regeneron's blockbuster retinal disease drug, EYLEA, continues to be a force to reckon with, clocking sales of $7.9 billion globally (in conjucnction with Bayer).

  • Should You Follow Cathie Wood Into This Coronavirus Stock?
    Motley Fool

    Should You Follow Cathie Wood Into This Coronavirus Stock?

    Cathie Wood, founder, CEO, and chief investment officer (CIO) of ARK Invest. Earlier this month, the ARK Genomic Revolution fund purchased more than 100,000 shares of Regeneron Pharmaceuticals (NASDAQ: REGN). Regeneron, maker of an antibody cocktail to treat COVID-19, is the fund's fourth-biggest holding.

  • 3 Reasons to Buy Ocular Therapeutix Stock Right Now
    Motley Fool

    3 Reasons to Buy Ocular Therapeutix Stock Right Now

    Shares of Ocular Therapeutix (NASDAQ: OCUL) have more than tripled investors' money over the past year as the company's long-lasting eye treatments took big steps forward. Despite the big gains it's already produced, this soaring biotech stock hasn't reached a peak yet. Like most smart investment decisions, there's more than one good reason to buy Ocular Therapeutix at the moment.